Background: The authors previously hypothesized the role of epigenetics in pathophysiology of delirium, and tested DNA methylation (DNAm) change among pro-inflammatory cytokines along with aging in blood, glia and neuron. The authors reported that DNAm level of the TNF-alpha decreases along with aging in blood and glia, but not in neuron; however, DNAm differences between delirium cases and non-delirium controls have not been investigated directly. Therefore, in the present study, DNAm differences in blood between delirium patients and controls without delirium were examined.
INTRODUCTION
Delirium among elderly patients is dangerous and common-it occurs in 15-53% of elderly patients after surgery, and in 70-87% of those in intensive care (1) ; however, it is underdiagnosed and undertreated (2) . Delirium is notorious for its association with a long term cognitive decline (3) and high mortality (4, 5) . Given that our society is aging, it is becoming increasingly important to predict which patients are at risk of experiencing delirium. Previous searches for biomarkers have revealed increased serum levels of inflammatory markers (6, 7) and cytokines (8, 9) among elderly patients with delirium. Similarly, studies in animal models have shown that cognitive disturbances (10) in response to exogenous insults increase with age and that cytokine release from microglia play a key role (11) . Thus, it is possible that microglia and inflammatory cytokines play a role in the pathogenesis of delirium in humans. However, the mechanisms whereby cytokine release or neuro-inflammation is enhanced with aging remain unclear, and identifying the patients in whom this occurs and optimizing their care will require reliable biomarkers.
Given the fact that aging and inflammation are the key risk factors of delirium, we focused on the fact that DNA methylation (DNAm) changes dynamically over the human lifespan and that epigenetic mechanisms control the expression of genes including those of cytokines. Thus, we hypothesized that epigenetic modifications specific to aging and delirium susceptibility occur in microglia; that similar modifications occur in blood; and that these epigenetic changes enhance reactions to exogenous insult, resulting in increased cytokine expression and delirium susceptibility (12) . In fact, no published study has assessed DNAm and its relationship to delirium in humans, especially with genome-wide DNAm investigation.
To support this hypothesis of DNAm change along with aging among pro-inflammatory cytokines, we previously reported that DNAm levels in blood decrease along with aging on the pro-inflammatory cytokine gene TNF-alpha, based on 265 participants from the Grady Trauma Project (GTP) (12) . We also showed that expression level of TNF-alpha among the same subjects increased with aging (12) . This data supports our hypothesis that in pro-inflammatory cytokine genes, DNAm levels decrease along with aging, and expression level increase. In addition, using a unique dataset from our own study comparing DNAm status from neurosurgically resected live human brains followed by fluorescence-activated cell sorting (FACS), we showed that DNAm of the TNF-alpha universally decreases with age among the glial (neuronal negative) component, but no such patterns were found among neurons (neuronal positive component) (12) . This data also supports our hypothesis that the DNAm in proinflammatory genes decrease in glia along with aging, making microglia potentially more prone to express those cytokine genes and to have highghtend inflammatory response when exposed to external stimuli such as surgery or infection leading to delirium.
However, what was lacking in our previous data was that we did not directly test DNAm differences between delirium cases and non-delirium controls. To fill this gap, we conducted the present study to compare DNAm status in blood from hospitalized patients with and without delirium to identify clinically useful epigenetic biomarkers for delirium from blood samples, which are routinely obtained from patients. We used blood for three reasons: 1) the function of monocytes in the blood is similar to that of microglia in that both release cytokines in response to exogenous stimulus, 2) our comparison of DNAm levels in live brain tissue (resected during neurosurgery) to those in blood from same individual collected at the same time point showed a high level of correlation genome-wide (13), and 3) our previous data showed a similar ageassociated decrease in DNAm in the pro-inflammatory cytokine gene TNF-alpha among glia and blood (12) . To accomplish these goals, we conducted the present study investigating DNAm differences in blood between delirium patients and controls without delirium.
To be comprehensive, we employed genome-wide approach using Illumina EPIC array. We first tested the pro-inflammatory cytokine gene, TNF-alpha, and its correlations with age between groups with and without delirium. We also conducted network analysis by using the top differentially methylated CpGs between the two groups. Lastly, we compared DNAm age between the two groups.
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METHODS AND MATERIALS
Subjects and Sample Collection
Study participants were co-enrolled when they were enrolled for a separate, ongoing study of delirium. A more detailed overview of study participants' recruitment process has been described previously (14) . Briefly, 92 subjects were recruited for this epigenetics study between November 2017 and October 2018 at the University of Iowa Hospitals and Clinics. This study was approved by the University of Iowa's Human Subjects Research Institutional Review Board.
Delirium Status Definition
A more detailed overview of study participants' phenotyping has been described previously (14) .
Briefly, we screened potential study participants for the presence of delirium by reviewing hospital records and by administering the Confusion Assessment Method for Intensive Care Unit (CAM-ICU) (15), the Delirium Rating Scale -Revised-98 (DRS-R-98) (16) , and the Delirium Observation Screening Scale (DOSS) (17) . A final decision of delirium category was conducted by a trained psychiatrist (G.S.) with detailed chart review.
Sample Processing and Epigenetics Methods
Written informed consent was obtained, and whole blood samples were collected in EDTA tubes. All samples were stored at −80 °C. Methylome assays were performed as previously described (13) . Briefly, genomic DNA was isolated from whole blood with the MasterPure TM DNA Purification kit (Epicentre, MCD85201). Genomic DNA was bisulfite-converted with the EZ DNA Methylation™ Kit (Zymo Research, D5002). DNAm of 93 samples (two samples were from one subject) was analyzed with the Infinium HumanMethylationEPIC BeadChip™ Kit (Illumina, WG-317-1002). Raw data was processed with the R packages ChAMP (18) and minfi (19, 20) .
One sample was filtered out because it had > 0.1 of CpG sites with detection p-values > 0.01, and CpG sites were filtered out as described below with ChAMP. As a result, 92 samples and 701,196 probes remained. Then, quality control and exploratory analysis were conducted. The density and multidimensional scaling plots showed 5 outliers. Two of them were the duplicate samples from one subject. The remaining 87 samples were processed again using ChAMP. The probes were filtered out if they 1) had a detection p-value > 0.01 (12,903 probes), 2) had less than 3 beads in at least 5% of samples per probe (8, 280 
RESULTS
Study Subjects Demographics
43 delirium case and 44 non-delirium control subjects were enrolled (age average 70.2 years, SD 10.2, range 42-101 years). Age and gender proportions were not statistically different between cases and controls. The total scores of the DRS-R-98 and DOSS were significantly higher in delirium cases than in non-delirium controls (Supplementary Table 1 ).
Comparison of Delirium Cases vs Non-delirium Controls in the TNF-alpha Gene
Whole blood samples from 87 samples (43 delirium and 44 non-delirium, age range 42-101 years) after filtering were analyzed using the EPIC array for genome-wide DNAm analysis.
There were no significant differences in CD8 T cells, natural killer cells, and B cells between delirium cases and non-delirium controls ( Supplementary Table 1 ). Among them, first, we specifically tested correlation between age and DNAm levels at 24 CpGs in the TNF-alpha gene tested on the Illumina EPIC array as shown in Table 1 .Delirium cases showed 3 significant CpGs after correction for multiple testing level (p < 0.05/24 = 0.00208), whereas non-delirium controls showed no significant CpGs after correction for multiple testing level.
Network Analysis
Next, we directly tested genome-wide DNAm differences between delirium cases and nondelirium controls. Volcano plots for the distribution of individual CpG differences and their corresponding logarithmic transformed p-values are shown in Figure 1 . The top 20 differentially methylated CpGs between delirium cases and non-delirium controls are shown in Supplementary Table 2 . Genome-wide analysis showed a top hit at cg21295729 with genomewide significance (p = 5.07E-8). This CpG is located near the gene LDLRAD4. Network analysis was conducted by using the CpGs with methylation level differences greater than 5.0% and p-9 value < 0.0005 (n = 753). By using those genes, network analysis showed the following results of the top 20 pathways with GO ( Table 2 ) and KEGG analysis ( Table 3 ). The top pathways with GO were immune response and myeloid leukocyte activation, and with KEGG were aldosterone synthesis/secretion and cholinergic synapse. Supplementary Table 3 also shows the significant pathways of GO analysis with false discovery rate (FDR)-adjusted p-value < 0.05.
Comparison of Delirium Cases vs Non-delirium Controls: DNAm Age
We further tested differences of DNAm age between delirium cases and non-delirium controls.
DNAm age showed signficant correlation with chronological age among delirium cases (r = 0.78, p < 0.001) and non-delirium controls (r = 0.67, p < 0.001). DNAm age among the non-delirium controls showed "slower aging" compared to the delirium cases, although there was no statistically significant difference ( Figure 2 ).
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DISCUSSION This is the first study comparing epigenetics status, especially genome-wide DNAm, between patients with and without delirium. The data presented here is consistent with our hypothesis that decreased levels of DNAm on pro-inflammatory cytokines along with aging can lead to hightened inflammation associated with delirium, whereas in patients without delirium DNAm levels remain high, and thus inflammatory reaction could be suppressed and they are protected against delirium.
In the present study, only delirium cases showed significant CpGs with multiple comparison adjusted level between age and decreasing level of TNF-alpha DNAm. This result is consistent with our hypothesis that the DNAm level of pro-inflammatory genes decrease along with aging in delirium patients. We speculate that delirium patients may have persistent decline of DNAm levels in the TNF-alpha gene along with aging, and this may have led to onset of delirium with an additional medical condition, requiring them to be admitted to a hospital. On the other hand, patients without delirium had less decline of DNAm levels in the TNF-alpha gene with aging, thus it might have protected them from developing delirium. To confirm this speculation, we need to conduct a large, prospective study comparing patient population as similar as possible in terms of their medication conditions. Studying surgical patients where you can collect samples before their exposure to surgery would be idealy for such investigation.
From genome-wide DNAm analysis, one genome-wide significant signal in the gene of LDLRAD4 was identified. LDLRAD4-low-density lipoprotein receptor class A domain containing 4-functions as a negative regulator of TGF-beta signaling that regulates the growth, differentiation, apoptosis, motility, and matrix protein production of a lot of cell types (32).
Although it was not genome-wide significant, one of the top hit CpGs was near the gene DAPK1. DAPK1-death associated protein kinase 1-functions as regulating apotosis, autophagy and inflammation (33) . It is reported that DAPK1 levels are induced by TNF-alpha and interferon-1 1 gamma (34) . The other top hit CpG was near the gene IRF8. IRF8-interferon regulatory factor 8-functions as a modulating of the immune response, cell growth, and oncogenesis (35) . It is reported that IRF8 has an important role as a regulator of reactive microglia (36) .
Although a potential role of these specific genes in pathophysiology of delirium requires further investigation, network analysis identified several top pathways relevant to neurofunction and inflammatory/immune processes, including immune response, leukocyte activation, neutrophil activation, and myeloid cell activation involved in immune response from GO analysis. Many pathways relevant to delirium and neural function were also identified from KEGG analysis, including cholinergic synapse, serotonergic synapse, and leukocyte transendothelial migration.
The cholinergic synapse was second from the top KEGG pathways. The cholinergic system is one of the most important neurotransmitter systems in the brain, and deficiency of acetylcholine is well known to be associated with delirium (37, 38) . The results of the present study are further supporting the relevance of cholinergic function in potential pathophysiology of delirium.
Furthermore, the pathways of positive regulation and regulation of interleukin-10 production, and positive regulation of interleukin-17 production, were significant (FDR-adjusted p-value < 0.05) from GO analysis. This result is also suggesting the role of pro-inflammatory cytokines and neuro-inflammation in pathophysiology of delirium, consistent with our hypothesis. These findings may support the validity of this epigenetic investigation of delirium pathophysiology.
We showed that DNAm age was significantly correlated with chronological age in both delirium cases and non-delirium controls. However, non-delirium cases showed relatively slower progression of DNAm aging along with chronological aging than delirium cases. DNAm age measures the accumulative effect of an epigenetic maintenance system (27) and predicts mortality (39, 40) . We speculate that non-delirium controls may have a protective mechanism against DNAm aging, which can also prevent developing delirium. With a larger sample size study we can test if DNAm aging is in fact different between delirium cases versus controls.
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There are several limitations in our study. First, the sample size is relatively small. To overcome this limitation, we need to increase the sample size in the future. Second, medical conditions required them to be hospitalized were diverse among study subjects including in the present study. As mentioned previously, comparing those with and without delirium after same type of surgery (post-operative delirium) would help minimize confounding factors. However, even with these limitation, the presented data showed supporting evidence of epigenetic differences in the pro-inflammatory cytokine gene TNF-alpha and in the immune/inflammatory response network and cholinergic system. Lastly, we used only blood samples and did not investigate brain tissues directly. However, there is a significant correlation between brain tissue and blood in DNAm levels, as shown in our previous study (13) . Also, as the goal of our study is to identify potentially clinically useful biomarkers, we believe that investigating DNAm differences in blood associated with delirium is important to improve our future clinical practice.
In conclusion, to the best of our knowledge, this is the first epigenetics study of delirium. The DNAm was investigated genome-wide. The results were consistent with our previous work and hypothesis (12) . Despite these limitations mentioned above, we showed evidence of epigenetic differences both at gene levels and network levels between delirium cases and non-delirium controls. This finding indicates that DNAm status in blood may become a useful epigenetic biomarker for delirium. 
